Literature DB >> 18305915

[HIV, AIDS and the cardiovascular risk].

T Neumann1.   

Abstract

The infection with the human immunodeficiency virus (HIV) is not only associated with a dysfunction of the immune system. Other organs are often affected in patients with HIV-infection, as well. In particular, an increased cardiovascular risk profile leads to an increasing rate of morbidity and mortality due to cardiac disorders, including heart failure and HIV-associated cardiomyopathy in this patient population. However, not only classic risk factors such as smoking, hypertension or dysregulation of lipid and glucose metabolisms are the reasons of HIV-associated myocardial dysfunction. Especially these subjects are also prone to opportunistic infections, side effects of antiretroviral therapy or the HI-virus itself.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305915     DOI: 10.1007/s00108-008-2049-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  20 in total

Review 1.  Cardiovascular manifestations of HIV infection.

Authors:  Giuseppe Barbaro
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

2.  Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences.

Authors:  Till Neumann; T Woiwod; A Neumann; B Ross; C Von Birgelen; L Volbracht; Norbert H Brockmeyer; G Gerken; R Erbel
Journal:  Eur J Med Res       Date:  2004-02-27       Impact factor: 2.175

Review 3.  [Premature arteriosclerosis in HIV-infected patients? Current status].

Authors:  Christian Hoffmann
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

Review 4.  [Cardiac manifestations in HIV-infected individual].

Authors:  Till Neumann; Birgit Ross; Ulrich R Hengge; Guido Gerken; Raimund Erbel
Journal:  Med Klin (Munich)       Date:  2002-11-15

5.  Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

Authors:  G Behrens; A Dejam; H Schmidt; H J Balks; G Brabant; T Körner; M Stoll; R E Schmidt
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

Review 6.  Cardiac involvement in HIV infection.

Authors:  R C Patel; W H Frishman
Journal:  Med Clin North Am       Date:  1996-11       Impact factor: 5.456

7.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

8.  Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital.

Authors:  V P Roy; S Prabhakar; J Pulvirenti; J Mathew
Journal:  J Natl Med Assoc       Date:  1999-09       Impact factor: 1.798

9.  Heart muscle disease related to HIV infection: prognostic implications.

Authors:  P F Currie; A J Jacob; A R Foreman; R A Elton; R P Brettle; N A Boon
Journal:  BMJ       Date:  1994-12-17

10.  Infection of the heart by the human immunodeficiency virus.

Authors:  W W Grody; L Cheng; W Lewis
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

View more
  1 in total

1.  [BNP in HIV-infected patients].

Authors:  Till Neumann; Nico Reinsch; Kathrin Neuhaus; Norbert Brockmeyer; Anja Potthoff; Stefan Esser; Martin Hower; Anja Neumann; Sarah Mostardt; Götz Gelbrich; Raimund Erbel
Journal:  Herz       Date:  2009-12       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.